Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices 17441 

napa@hhs.gov and put ‘‘April 28 

Meeting Attendance’’ in the Subject line 

by Friday, April 17, so that their names 

may be put on a list of expected 

attendees and forwarded to the security 

officers at the Department of Health and 

Human Services. Any interested 

member of the public who is a non-U.S. 

citizen should include this information 

at the time of registration to ensure that 

the appropriate security procedure to 

gain entry to the building is carried out. 

Although the meeting is open to the 

public, procedures governing security 

and the entrance to Federal buildings 

may change without notice. If you wish 

to make a public comment, you must 

note that within your email. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is given under the 

Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)(1) and 

(a)(2)). Topics of the Meeting: The 

Advisory Council will hear 

presentations on the basics of long-term 

care, including presentations on 

programs, settings, and payers. The 

Council will use a portion of the 

meeting to review the work it has 

accomplished thus far towards the 2025 

goals, and then discuss the process for 

developing recommendations for the 

2015 update to the National Plan. The 

Council will also hear presentations 

from the three subcommittees (Research, 

Clinical Care, Long-Term Services and 

Supports, and Ethics). 

Procedure and Agenda: This meeting 

is open to the public. Please allow 30 

minutes to go through security and walk 

to the meeting room. The meeting will 

also be webcast at www.hhs.gov/live. 

Authority: 42 U.S.C. 11225; Section 2(e)(3) 

of the National Alzheimer’s Project Act. The 

panel is governed by provisions of Public 

Law 92–463, as amended (5 U.S.C. Appendix 

2), which sets forth standards for the 

formation and use of advisory committees. 

Dated: March 25, 2015. 

Richard G. Frank, 

Assistant Secretary for Planning and 

Evaluation. 

[FR Doc. 2015–07374 Filed 3–31–15; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of Dietary Supplements VDSP 

Commutability Study 2 

SUMMARY: NIH Office of Dietary 

Supplements (ODS) and the National 

Institute of Standards and Technology 

(NIST), in collaboration with the College 

of American Pathologists (CAP) and 

Vitamin D External Quality Assessment 

Scheme (DEQAS), announce that as part 

of the Vitamin D Standardization 

Program (VDSP), they are recruiting 

laboratories to participate in a study of 

the commutability of pooled serum 

samples used in assays to measure total 

25-hydroxyvitamin D [25(OH)D]. 

DATES: The expected start date for the 

study is June 2015. 

ADDRESSES: For more information about 

the study and to let us know if you are 

interested in participating, please 

contact us at: vdsp@mail.nih.gov. 

FOR FURTHER INFORMATION CONTACT: Drs. 

Johanna Camara, NIST, and Christopher 

Sempos, ODS, Director and Co-Director, 

respectively, for the VDSP 

Commutability Study 2. Email: VDSP@

mail.nih.gov. 

SUPPLEMENTARY INFORMATION: The 

objective of the study is to promote the 

standardized measurement of total 

25(OH)D by evaluating the 

commutability of NIST Standard 

Reference Materials® (SRM) used as 

‘‘trueness’’ controls and the materials 

used in the major Performance Testing/ 

External Quality (PT/EQA) programs 

administered by CAP and DEQAS. Who 

Can Participate: (1) All commercial 

manufacturers of 25(OH)D assays 

(requests from manufacturers with 

assays in development will be 

considered); (2) Clinical and research 

laboratories using a commercial assay 

platform; (3) Laboratories for national/

subnational nutrition surveys; and (4) 

Laboratories using in-house developed 

assays. 

For details about the study design and 

time lines, see the recently published 

paper in the February 2015 edition of 

Clinical Laboratory News, (https://

www.aacc.org/publications/cln/articles/

2015/february/vitamin-dcommutability-study). 

Dated: March 24, 2015. 

Lawrence A. Tabak, 

Deputy Director, National Institutes of Health. 

[FR Doc. 2015–07326 Filed 3–31–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Fibroblast 

Growth Factor And Aging. 

Date: May 1, 2015. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, Suite 2C212, 7201 

Wisconsin Avenue, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Alicja L. Markowska, 

Ph.D., DSC., Scientific Review Branch, 

National Institute On Aging, 7201 Wisconsin 

Avenue, Suite 2c212, Bethesda, MD 20892, 

301–496–9666, markowsa@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: March 26, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–07338 Filed 3–31–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, NIA. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

NATIONAL INSTITUTE ON AGING, 

including consideration of personnel 

qualifications and performance, and the 

mstockstill on DSK4VPTVN1PROD with NOTICES